Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology
<h4>Background</h4> Outcome measures available for use in Alzheimer’s disease (AD) clinical trials are limited in ability to detect gradual changes. Measures of everyday function and cognition assessed unobtrusively at home using embedded sensing and computing generated “digital biomarke...
Main Authors: | Nathan C. Hantke, Jeffrey Kaye, Nora Mattek, Chao-Yi Wu, Hiroko H. Dodge, Zachary Beattie, Randy Woltjer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249904/?tool=EBI |
Similar Items
-
Correlating continuously captured home-based digital biomarkers of daily function with postmortem neurodegenerative neuropathology.
by: Nathan C Hantke, et al.
Published: (2023-01-01) -
Association Between Mild Cognitive Impairment and Seasonal Rest-Activity Patterns of Older Adults
by: Christina Reynolds, et al.
Published: (2022-02-01) -
Reproducibility and replicability of high‐frequency, in‐home digital biomarkers in reducing sample sizes for clinical trials
by: Chao‐Yi Wu, et al.
Published: (2021-01-01) -
Use of High-Frequency In-Home Monitoring Data May Reduce Sample Sizes Needed in Clinical Trials.
by: Hiroko H Dodge, et al.
Published: (2015-01-01) -
In-Home Mobility Frequency and Stability in Older Adults Living Alone With or Without MCI: Introduction of New Metrics
by: Chao-Yi Wu, et al.
Published: (2021-10-01)